openPR Logo
Press release

Peanut Allergy Pipeline Landscape Analysis of 15+ Companies by DelveInsight

09-29-2022 10:33 AM CET | Health & Medicine

Press release from: DelveInsight Business Research

Peanut Allergy Pipeline Landscape Analysis of 15+ Companies

Peanut Allergy Pipeline constitutes 15+ key companies continuously working towards developing 15+ Peanut Allergy Treatment therapies, analyzed DelveInsight

Peanut Allergy Pipeline Report provides comprehensive global coverage of available, marketed, and pipeline Peanut Allergy therapies in various stages of clinical development, major pharmaceutical companies are working to advance the pipeline space and future growth potential of the Peanut Allergy Pipeline Domain.

Key takeaways from the Peanut Allergy Pipeline Report
• DelveInsight's Peanut Allergy Pipeline analysis depicts the space with 15+ active players working to develop 15+ pipeline therapies.
• The Peanut Allergy Pipeline report encloses its detailed analysis of various drugs in different stages of clinical development, including phase II, I, preclinical, and Discovery.
• Key Peanut Allergy Companies such as DBV Technologies, Regeneron Pharmaceuticals, Cour Pharmaceutical, HAL Allergy, InnoUp Farma S.L., Vedanta Biosciences, Astellas Pharma, Intrommune Therapeutics, Genentech, ASIT biotech, BlueWillow Biologics, Allergy Therapeutics, Alladapt Immunotherapeutics, Desentum, Camallergy, Prota Therapeutics, IgGenix, and many others
• Promising Peanut Allergy in the pipeline in various stages of development include Viaskin Peanut, Dupilumab, CNP-201, and many others
Request a sample and discover the recent advances in Peanut Allergy @ https://www.delveinsight.com/sample-request/peanut-allergy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

The Peanut Allergy Pipeline report provides detailed profiles of pipeline assets, a comparative analysis of clinical and non-clinical stage Peanut Allergy, inactive and dormant assets, a comprehensive assessment of driving and restraining factors, and an assessment of opportunities and risks in the T Peanut Allergy pipeline landscape.

Peanut Allergy Overview
A peanut allergy is a reaction that occurs when your body mistakenly identifies peanuts as harmful substances. When you eat peanuts or food containing peanuts, your immune system -the body's natural defense system that fights infections and diseases-overreacts and can cause a serious, even life-threatening response. Symptoms of peanut allergy can range from mild to severe. If you have a mild reaction, you may get a stomachache, a runny nose, itchy eyes, hives, or tingling in your lips or tongue. Your symptoms may start from within a few minutes to a few hours after eating peanuts or peanut products.

DelveInsight's Peanut Allergy Pipeline Report covers around 15+ products under different phases of clinical development like
• Late stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I) along with the details of
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration

Emerging Peanut Allergy Drugs under Different Phases of Clinical Development Include:-
• Viaskin Peanut: DBV Technologies
• Dupilumab: Regeneron Pharmaceuticals/Sanofi
• CNP-201: Cour Pharmaceutical
Learn more about the emerging Peanut Allergy @ https://www.delveinsight.com/sample-request/peanut-allergy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Peanut Allergy Pipeline Therapeutics Analysis
There are approx. 15+ key companies which are developing the therapies for Peanut Allergy. The companies which have their Peanut Allergy drug candidates in the most advanced stage, i.e. preregistration include, DBV Technologies.

Peanut Allergy Pipeline Report provides insights into:
• All of the companies that are developing therapies for the treatment of Peanut Allergy with aggregate therapies developed by each company for the same.
• Different therapeutic candidates segmented into early-stage, mid-stage and late stage of development for the Peanut Allergy
• Peanut Allergy key players involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of Peanut Allergy

The Peanut Allergy Pipeline Report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

Scope of the Peanut Allergy Pipeline Report
• Coverage- Global
• Peanut Allergy Pipeline Assessment by Product Type
• Peanut Allergy Pipeline Assessment by Stage and Product Type
• Peanut Allergy Pipeline Assessment by Route of Administration
• Peanut Allergy Pipeline Assessment by Stage and Route of Administration
• Peanut Allergy Pipeline Assessment by Molecule Type
• Peanut Allergy Pipeline Assessment by Stage and Molecule Type
• Peanut Allergy Pipeline Companies- DBV Technologies, Regeneron Pharmaceuticals, Cour Pharmaceutical, HAL Allergy, InnoUp Farma S.L., Vedanta Biosciences, Astellas Pharma, Intrommune Therapeutics, Genentech, ASIT biotech, BlueWillow Biologics, Allergy Therapeutics, Alladapt Immunotherapeutics, Desentum, Camallergy, Prota Therapeutics, IgGenix, and many others
• Peanut Allergy Pipeline Therapies- Viaskin Peanut, Dupilumab, CNP-201, and many others

Table of Content
1. Introduction
2. Executive Summary
3. Peanut Allergy: Overview
4. Pipeline Therapeutics
5. Therapeutic Assessment
6. Late Stage Products (Preregistration)
7. Viaskin Peanut: DBV Technologies
8. Mid Stage Products (Phase II)
9. Dupilumab: Regeneron Pharmaceuticals
10. Early Stage Products (Phase I/II)
11. CNP-201: Cour Pharmaceutical
12. Preclinical and Discovery Stage Products
13. Peanut-NE01 vaccine: BlueWillow Biologics
14. Inactive Products
15. Peanut Allergy Key Companies
16. Peanut Allergy Key Products
17. Peanut Allergy- Unmet Needs
18. Peanut Allergy- Market Drivers and Barriers
19. Peanut Allergy- Future Perspectives and Conclusion
20. Peanut Allergy Analyst Views
21. Peanut Allergy Key Companies
22. Appendix

For further information on the Peanut Allergy Pipeline therapeutics, reach out @ https://www.delveinsight.com/report-store/peanut-allergy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: info@delveinsight.com
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Peanut Allergy Pipeline Landscape Analysis of 15+ Companies by DelveInsight here

News-ID: 2753114 • Views:

More Releases from DelveInsight Business Research

Global Patient Engagement Solutions Market to reach USD 59,499.28 million by 2034 at a CAGR of 12.15% by 2032, Evaluates DelveInsight
Global Patient Engagement Solutions Market to reach USD 59,499.28 million by 203 …
According to DelveInsight's analysis, The growth of the patient engagement solutions market is primarily fueled by several major factors, including the increasing burden of chronic conditions such as diabetes and cardiovascular diseases, which require continuous patient involvement and monitoring. The industry is further propelled by the move toward patient-centric healthcare models, ongoing technological innovations, and the introduction of new digital tools and platforms. Moreover, supportive government policies and initiatives aimed
Global Magnetic Resonance Imaging Devices Market to reach USD 13,553.33 million by 2032 at a CAGR of 6.54% by 2032, Evaluates DelveInsight
Global Magnetic Resonance Imaging Devices Market to reach USD 13,553.33 million …
According to DelveInsight's analysis, The growing incidence of chronic illnesses-including heart disease, cancer, and neurological disorders is driving demand for advanced diagnostic methods such as MRI, which provides highly detailed imaging of soft tissues and internal organs. Increasing awareness and a stronger focus on early disease detection are also prompting both patients and healthcare professionals to rely on MRI for faster and more accurate diagnosis. In addition, ongoing technological progress
Global Microbial Fermentation Technology Market Size was USD 33,956.10 million in 2024 at a CAGR of 5.24% by 2032, Evaluates DelveInsight
Global Microbial Fermentation Technology Market Size was USD 33,956.10 million i …
According to DelveInsight's analysis, The microbial fermentation technology market is experiencing strong growth, largely due to the increasing incidence of chronic illnesses such as cancer and a range of infectious diseases, including HIV, hepatitis B and C, and influenza. The market is also being boosted by the rising need for advanced therapeutic products like cell therapies, monoclonal antibodies, recombinant proteins, and gene therapies. Moreover, progress in synthetic biology and precision
Global Surgical Robotic System Market to reach USD 29,785.13 million by 2032 at a CAGR of 13.21% by 2032, Evaluates DelveInsight
Global Surgical Robotic System Market to reach USD 29,785.13 million by 2032 at …
According to DelveInsight's analysis, The growing prevalence of chronic illnesses such as cancer, cardiovascular diseases, and orthopedic disorders is driving demand for advanced surgical solutions, which in turn is accelerating the expansion of the surgical robotic systems market. Since many of these conditions require complex, highly precise procedures, robotic-assisted surgery is becoming a preferred option due to its superior precision, less invasive nature, and faster patient recovery. At the same

All 5 Releases


More Releases for Peanut

Peanut Butter Market 2020-2027 Advance Study Focusing On Major Product Types- S …
Peanut Butter Market Overview 2020-2027: Peanut butter market is anticipated to dominate the market with a market value of USD 4.20 billion in 2019 and is expected to grow with a growth rate of 6.10% in the forecast period of 2020 to 2027.  The latest Market report by a Data Bridge Market Research with the title [Global Peanut Butter Market – Industry Trends and Forecast to 2027].  Get a PDF Sample copy (including COVID-19 impact analysis and up-to 30% discount ) @  https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-peanut-butter-market  In
Peanut Butter Manufacturing Unit
Peanut butter is a high calorie, high protein product manufactured by grinding peanuts. It is a good alternative for dairy butter and widely used as a bread spread. Peanut butter is popular amongst Americans, and it is a part of their daily breakfast. The demand for peanut butter is susceptible to consumer spending. As disposable income increases, the willingness of the people to purchase the peanut butter also increases. On
Peanut Sauce Market 2019 | Worldwide Forecast 2025 | Major Players – Jif, PBfi …
Peanut Sauce Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. Get Exclusive FREE Sample Copy Of this Report @ https://www.upmarketresearch.com/home/requested_sample/85716 UpMarketResearch offers a latest published report on “Global Peanut Sauce Market Analysis and Forecast 2019 - 2025” delivering key insights and providing a competitive advantage
Drinkable Peanut Powder Market | Top Key Players are Golden Peanut and Tree Nuts …
Peanuts are a high-protein, nutritious food that are ready-to-eat with little preparation or can be eaten raw. Peanut can be processed by roasting and ground into various food products. Peanut shakes and smoothies segments are gaining significant traction in the global drinkable peanut powder market. Rising demand for the healthy beverages such as drinkable peanut powder products driving the market. In addition, food manufacturers are developing peanut powder which is based
Hormel Foods, J.M. Smucker Company, Saratoga Peanut Butter Company, Peanut Butte …
The market for Peanut Paste is growing with the expansion of this Industry Sector Worldwide. Market Research Hub (MRH) has added a new report titled “Global Peanut Paste Market Insights, Forecast to 2025” which offer details about the current trends and analysis, as well as scope for the near future. This research study also covers information about the production, consumption and market share based on different active regions. Furthermore, an
Peanut Butter Market Report 2018: Segmentation by Product (Regular Peanut Butter …
Global Peanut Butter market research report provides company profile for Hormel Foods Corporation, Boulder Brands, Kraft Canada, Algood Food Company, Procter & Gamble, Unilever, The J.M. Smucker Company and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018